Pharmaceuticals, Biotechnology and Life Sciences
Novocure will present EF-19 data which confirm the effectiveness and safety of Optune as monotherapy and further strengthen Optune’s clinical profile in recurrent GBM.
Flow chemistry engineering firm Vapourtec is looking to collaborate with industrial and academic organisations by offering its resources and experience to those currently involved in the fight against Coronavirus.
AstraZeneca has updated use of Lokelma based on data from Phase IIIb DIALIZE trial.
Data showed the efficacy and safety of Keytruda 400 mg every six weeks (Q6W) comparable to approved 200 mg every three weeks (Q3W) regimen.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and the Institute for Systems Biology (ISB), today announced a new research collaboration to investigate and define the molecular mechanisms of SARS-CoV-2 infection and COVID-19 and identify targets for medicines and vaccines.
AstraZeneca and Merck revealed further positive results from the Phase 3 PROfound trial evaluating LYNPARZA in men with metastatic castration-resistant prostate cancer (mCRPC).
Devonian Health Group has increased its non-brokered financing to $2M.
LONDON–(BUSINESS WIRE)–#Analytics—Quantzig, global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has been…
ALung has received FDA’s emergency use authorisation designation to the Hemolung respiratory assist system for treatment of COVID-19 patients.
172 of its affiliated hospitals are participating in a national study to test whether plasma from convalescent, or recovered, COVID-19 patients may help in the treatment of individuals currently sick from the virus.